Terumo Corporation (TYO: 4543)

Market Cap	3.98T
Revenue (ttm)	964.81B
Net Income (ttm)	117.72B
Shares Out	1.48B
EPS (ttm)	79.15
PE Ratio	33.90
Forward PE	29.25
Dividend	26.00 (0.98%)
Ex-Dividend Date	Sep 27, 2024

Volume	4,372,900
Open	2,696.00
Previous Close	2,646.00
Day's Range	2,602.50 - 2,714.50
52-Week Range	1,856.00 - 3,014.50
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 11, 2024

About Terumo

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1921
• Employees: 30,591
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4543

Financial Performance

In 2023, Terumo's revenue was 921.86 billion, an increase of 12.39% compared to the previous year's 820.21 billion. Earnings were 106.37 billion, an increase of 19.09%.